Announcement • Jul 06
Afyren Resumes Production At Afyren Neoxy Plant After Technical Shutdown AFYREN announced the resumption of production at the AFYREN NEOXY plant after the successful technical shutdown of June. As part of the consolidation and performance improvement plan launched in 2025, AFYREN scheduled a one-month technical shutdown in June 2026 to modify existing and install new equipment in the downstream process. The works proceeded as planned and on budget: four weeks of work, six days out of seven, for a total 20,000 working hours and a total investment of around EUR 6 million. Up to 90 people have been working on site on certain days, drawn from around a dozen external companies, doubling the usual workforce at the AFYREN NEOXY plant. In the challenging conditions of intense heat, team safety remained the top priority throughout the shutdown, with zero accident with loss time reported. Following the works, production has resumed, and AFYREN expects an acceleration in production in the second half of 2026, after a first semester which saw revenue doubling compared with Fiscal year 2025. Announcement • Jun 17
AFYREN Approves Appointment of Giuseppe Abrate to the Board of Directors AFYREN announced that its shareholders approved the resolutions proposed and agreed by the Board of Directors and submitted to the Annual Ordinary and Extraordinary General Meeting held on June 16, 2026. These resolutions included the appointment to the Board of Directors of Mr. Giuseppe Abrate, representing Kemin Industries Inc., as a new director. Price Target Changed • May 27
Price target decreased by 16% to €4.35 Down from €5.20, the current price target is an average from 2 analysts. New target price is 62% above last closing price of €2.69. Stock is up 14% over the past year. The company is forecast to post a net loss per share of €0.41 next year compared to a net loss per share of €0.53 last year.